|

BG-89894 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: SYH2039

Pipeline

Phase 1: 2

Top Sponsors

  • BeOne Medicines2

Indications

  • Cancer2
  • Advanced or Metastatic MTAP-deleted Solid Tumors1
  • Advanced Solid Tumor1

Los Angeles, California1 trial

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Usc Norris Comprehensive Cancer Center (Nccc)

Phase 1

Baltimore, Maryland1 trial

An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

Sidney Kimmel Comprehensive Cancer At Johns Hopkins

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.